메뉴 건너뛰기




Volumn 16, Issue 5, 2015, Pages 455-457

Is personalized medicine a panacea for health management? Some thoughts on its desirability

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC PROCEDURE; DISEASE MANAGEMENT; ECONOMICS; GENETIC SCREENING; HUMAN; PERSONALIZED MEDICINE; PROCEDURES;

EID: 84939993453     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-014-0665-6     Document Type: Editorial
Times cited : (3)

References (6)
  • 2
    • 84902303965 scopus 로고    scopus 로고
    • Is individualized medicine more cost-effective? A systematic review
    • PID: 24574059
    • Hatz, M.H.M., Schremser, K., Rogowski, W.H.: Is individualized medicine more cost-effective? A systematic review. Pharmaco. Economics 32, 443–455 (2014)
    • (2014) PharmacoEconomics , vol.32 , pp. 443-455
    • Hatz, M.H.M.1    Schremser, K.2    Rogowski, W.H.3
  • 3
    • 33947712686 scopus 로고    scopus 로고
    • Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers
    • Trusheim, M.R., Berndt, E.R., Douglas, F.L.: Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov 6, 28793 (2007)
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 28793
    • Trusheim, M.R.1    Berndt, E.R.2    Douglas, F.L.3
  • 6
    • 84939955787 scopus 로고    scopus 로고
    • European Medicines Agency (EMA): EMA recommends approval of new treatment for platinum-resistant ovarian cancer together with companion diagnostic. accessed 28 November 2014
    • European Medicines Agency (EMA): EMA recommends approval of new treatment for platinum-resistant ovarian cancer together with companion diagnostic. Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/03/news_detail_002051.jsp&mid=WC0b01ac058004d5c1, accessed 28 November 2014


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.